science wire

Scientists are calling for the public to help save endangered Welsh bees by registering bee sightings, helping to protect precious pollinators in Wales.

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

Over the past decade, the number of NHS general practices in England has decreased by 20% with 15% fewer qualified fulltime equivalent (FTE) general practitioners (GPs) per 1,000 patients, finds a new analysis involving a UCL researcher.

Researchers have proposed a new classification system for angina patients, co-authoring a scientific consensus statement introducing new terminology for ischaemic heart disease, which is the leading cause of death in men and women worldwide.

A cancer drug that unlocks the anti-inflammatory power of the immune system could help to reduce the risk of future heart attacks, according to research part-funded by the British Heart Foundation.

For the last decade, people who use drugs in Quebec have been partially sheltered from Canada's drug overdose epidemics. But since 2020, the picture has changed. The contamination of the drug market is now present in Quebec, and what happened in British Columbia and Ontario is now happening here, says expert Sarah Larney.

A deeper understanding of the communication inside the body when someone is going through opioid withdrawal has led to a new clinical trial at the University of Calgary.

The University of Queensland is leading a trial across Brisbane and the Sunshine Coast focusing on improving the delivery of life-saving treatments for hospitalised babies.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer's disease in the UK, following decades of work supported by UCL research.

Bonn researchers clarify the influence of treatment with tetrahydrocannabinol on the metabolic switch mTOR A low-dose long-term administration of cannabis can not only reverse aging processes in the brain, but also has an anti-aging effect. Researchers from the University Hospital Bonn (UKB) and the University of Bonn together with a team from Hebrew University (Israel) have now been able to show this in mice.

A minimally invasive approach gives a better treatment option to certain patients with metastatic uveal melanoma Health + Behavior A minimally invasive approach gives a better treatment option to cert

Waterloo researchers awarded more than $4.3 million. University of Waterloo researchers take pride in identifying and solving significant, complex challenges facing humanity and our planet.

A unique influenza vaccine candidate that's inhaled and based on technology developed by University of Wisconsin-Madison researchers is safe and could bolster protection against seasonal and pandemic influenza for people vulnerable to severe disease when they receive it in addition to the annual flu shot.

One in four patients in vegetative or minimally conscious state able to perform cognitive tasks, study finds Around one in four patients with severe brain injury who cannot move or speak - because the

There is a need for comprehensive data on the long-term effects of weight loss drugs such as semaglutide or tirzapatide, as well as strategies for maintaining a healthier weight once people stop using them, argues a multidisciplinary team led by researchers from UCL.

Solving a decades-old problem, a multidisciplinary team of Caltech researchers has figured out a method to noninvasively and continually measure blood pressure anywhere on the body with next to no disruption to the patient. A device based on the new technique holds the promise to enable better vital-sign monitoring at home, in hospitals, and possibly even in remote locations where resources are limited.

University of Manchester scientists are part joining three of eight new networks, combining different research specialisms, to tackle one of humanity's biggest threats, antimicrobial resistance (AMR).

FDA approves brain cancer therapy that relies on Johns Hopkins genetic discovery The drug, vorasidenib, targets a mutated gene identified in 2008 by Hopkins cancer expert Bert Vogelstein and his team in collaboration with researchers at Duke University The U.S. Food and Drug Administration on Tuesday approved a new drug for brain cancer that stems from a 2008 genetic discovery made by researchers at the Johns Hopkins Sidney Kimmel Cancer Center.

A new study highlights the need for government support for large-scale badger vaccination to eradicate bovine tuberculosis. The study, published today in People and Nature , reports on the results of a four-year pilot badger vaccination programme co-managed between farmers, scientists, and conservationists.

Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.

A dream come truefor parents Rosemary and Darren whose daughter Nessa born during the UNITY trial participation.

A new tool from Imperial and Molecular Dimensions could help biologists rapidly uncover valuable insights into the proteins found in cell membranes. Imperial is working with the company to commercialise a high-throughput test that will help scientists to acquire fundamental knowledge about integral membrane proteins - components of living cells that are the targets for 60% of prescribed drugs.

The University of Queensland-led and developed COVID-19 Risk Calculator has been updated to determine a person's risk of developing long COVID.

A new four-year research programme will address poor access to quality primary healthcare for patients with COPD - South America's fourth leading cause of death Health experts from the University of Birmingham are launching a project that will help to identify and treat patients with Chronic Obstructive Pulmonary Disease (COPD) across South America.

Dramatically improve outcomes for thousands of people in the UK affected by stroke each year.

A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University of Illinois Chicago. For a new paper in Nature Chemical Biology, researchers probed how a class of synthetic drugs called macrolones disrupt bacterial cell function to fight infectious diseases.

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Work will begin soon on a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond.

A study from IOR, affiliated to USI, published in the journal Haematologica. explores the potent anti-cancer activity of loncastuximab tesirine, an antibody-drug conjugate (ADC) targeting CD19-positive B cell lymphomas. The research, led by Dr Chiara Tarantelli (IOR Senior Investigator) and Prof. Francesco Bertoni (IOR Group Leader and Deputy Director, USI Adjunct Professor), involves a collaborative effort from prominent institutions, including Case Western Reserve University, Fred Hutchinson Cancer Center, and Weill Cornell Medicine, among others.

The silkworm  (Bombyx mori ) and related species are among the oldest pets of mankind. The fascinating ability of these insects to spin a thread hundreds of metres long has been used for around 5,000 years.

Cancer cells are known to take advantage of a mechanism called cell competition, a quality control system that ensures that our tissues are composed of healthy cells.

When long-term users of prescription opioids in Canada were mailed a brochure encouraging them to cut their dosages, many of them did - and that's a good thing, researchers say.